Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
      • Neuroimmunology: To Sense and Protect
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • My alerts
  • Log in
  • Log out
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

Human Alternative Complement Pathway: Membrane-Associated Sialic Acid Regulates the Competition between B and β1H for Cell-Bound C3b

Michel D. Kazatchkine, Douglas T. Fearon and K. Frank Austen
J Immunol January 1, 1979, 122 (1) 75-81;
Michel D. Kazatchkine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Douglas T. Fearon
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
K. Frank Austen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

The relative affinity of B and β1H for particle-bound C3b is influenced by the relative abundance of cell surface sialic acid moieties and determines whether or not the particle has the capacity to activate the human alternative complement pathway. The effect of membrane sialic acid on the binding of B and β1H to particle bound C3b was determined with radiolabeled proteins and a technique for separating bound from free ligand by centrifugation of the particles through an oil/aqueous interphase. The affinity constants at equilibrium and the effective number of C3b binding sites for B and β1H on the particles were determined by Scatchard analysis of the binding data. The sheep erythrocyte (Es) served as a nonactivating particle, whereas the activating particles included Es from which 80% of the membrane sialic acid residues had been removed by sialidase or 80 to 85% had been converted to heptulosonic acid by NaIO4 and NaBH4 treatment and zymosan particles that lack sialic acid. The affinity constants at equilibrium for C3b on EsC3b were 1 × 107 M-1 for β1H and 2.1 × 106 M-1 for B, in the presence of 5 mM Mg++, indicating an approximately 5-fold greater affinity of β1H for the binding sites that were present in approximately equal numbers for the two ligands as determined by Scatchard analysis. The affinity of B at equilibrium for C3b bound to sialic acid-deficient sheep erythrocytes and to zymosan was the same as that for C3b on Es, and the calculated number of effective binding sites for B agreed with the number of sites estimated by the prior uptake of radiolabeled C3b. In contrast, the number of C3b binding sites with an affinity for β1H of approximately 107 M-1 on sialic acid-deficient EsC3b or ZyC3b was only ⅕ to ⅙ the number interacting with B. The presence of additional binding sites for β1H with an affinity so low that they were not revealed by the Scatchard analysis because of the dominant effect of the high affinity sites was determined in competitive binding studies between B and β1H for C3b on sialic acid-deficient surfaces. The affinity constant of β1H for these sialic acid independent C3b sites is approximately 7 × 105 M-1, a Kβ1H at least 10-fold less than that of the sialic acid-dependent high affinity C3b sites. The relative inefficiency of β1H in competing with 125I-B for uptake by C3b on the sialic acid-deficient erythrocytes correlated with the decreased capacity of β1H to decay-dissociate C3b,Bb from such particles. Thus a deficiency of sialic acid diminishes the number of high affinity C3b sites for β1H and creates an activating particle on which binding of B by C3b is favored relative to β1H and decay-dissociation of C3b,Bb by β1H is impaired.

Footnotes

  • ↵2 Fellow of the Delegation Generale a la Recherche Scientifique et Technique, D.G.R.S.T., France.

  • ↵3 Research Career Development Awardee (K04 AI-00245) from the National Institutes of Health.

  • ↵1 Supported by Grants AI-07722, AM-05577, and RR-05669 from the National Institutes of Health.

  • Received August 7, 1978.
  • Accepted October 6, 1978.
  • Copyright © 1979 by The American Association of Immunologists, Inc.
PreviousNext
Back to top

In this issue

The Journal of Immunology
Vol. 122, Issue 1
1 Jan 1979
  • Table of Contents
  • Table of Contents (PDF)
  • Advertising (PDF)
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Immunology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Human Alternative Complement Pathway: Membrane-Associated Sialic Acid Regulates the Competition between B and β1H for Cell-Bound C3b
(Your Name) has forwarded a page to you from The Journal of Immunology
(Your Name) thought you would like to see this page from the The Journal of Immunology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Human Alternative Complement Pathway: Membrane-Associated Sialic Acid Regulates the Competition between B and β1H for Cell-Bound C3b
Michel D. Kazatchkine, Douglas T. Fearon, K. Frank Austen
The Journal of Immunology January 1, 1979, 122 (1) 75-81;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Human Alternative Complement Pathway: Membrane-Associated Sialic Acid Regulates the Competition between B and β1H for Cell-Bound C3b
Michel D. Kazatchkine, Douglas T. Fearon, K. Frank Austen
The Journal of Immunology January 1, 1979, 122 (1) 75-81;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Brucella Abortus Lipopolysaccharide Is Mitogenic for Spleen Cells of Endotoxin-Resistant C3H/HeJ Mice
  • Induction of Lysosomal Enzyme Secretion by Alveolar Macrophages in Response to the Purified Complement Fragments C5a and C5a des-arg
  • Antibody-Independent Neutralization of Vesicular Stomatitis Virus by Human Complement
Show more Immunochemistry

Similar Articles

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • FAR 889
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2021 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606